
VIR vs ALVO
$VIR vs $ALVO head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
VIR vs ALVO: trend, levels and the market
One year to 2026-11-18, against the S&P 500 (+10.6%). Split-adjusted daily closes.
- ·VIR is the weaker of the two on trend, below both its 50- and 200-day averages, while ALVO has held above one of them.
- ·Only VIR beat the market over the past year, by 55.7%, while ALVO trailed the S&P 500 at +10.6% by 21.6%.
- ·The last month has flipped the order: ALVO has held up better over the month (-11.1% against -14.8%) even though VIR leads over the year.
- ·ALVO sits closer to its support, 23.3% above it at $3.49, while VIR is 33.6% above its own at $6.24.
- ·VIR is within 2% of resistance at $9.58, a price where it has stalled before.
- ·ALVO is within 1.1% of resistance at $4.60, a price where it has stalled before.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
VIR vs ALVO: the quick read
- ·VIR is the larger company by market cap ($1.58B vs $1.56B).
- ·VIR has been more active on our scanner (161 vs 90 alerts in 30 days).
- ·VIR has the smaller float (154.7M vs 247.2M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) vs Biological Products, (No Diagnostic Substances)), so they answer to different catalysts and a move in one says little about the other.
- ·Both stay busy on our scanner, 161 and 90 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 2% of each other on market cap, which makes the rest of this table the interesting part.
- ·VIR pays a dividend and ALVO does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Watching VIR or ALVO? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing VIR and ALVO on TheDesperateTrader.
- Is VIR or ALVO the better stock?
- "Better" depends on your goal, and these two are not alike. VIR is the larger company by market cap ($1.58B vs $1.56B). VIR has been more active on our scanner (161 vs 90 alerts in 30 days). VIR has the smaller float (154.7M vs 247.2M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between VIR and ALVO?
- The differences that matter: they are not in the same business - VIR is biological products, (no diagnostic substances) and ALVO is biological products, (no diagnostic substances); they are similar in size ($1.58B vs $1.56B); they trade at very different share prices ($9.39 vs $4.55); VIR sits at 45% of its 52-week range against 45% for ALVO; only VIR pays a dividend; our scanner flagged VIR 161 times in the last 30 days against 90 for ALVO. Everything above is measured from the latest completed session and SEC filings.
- Which of VIR and ALVO is more active right now?
- Right now VIR is at about 1.3x its normal volume and ALVO is at about 1.4x, so ALVO is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is VIR or ALVO in the stronger trend?
- VIR is below its 50-day average of $11.04 and below its 200-day average of $9.79; ALVO is below its 50-day average of $5.18 and above its 200-day average of $4.17. ALVO leads 3 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading VIR or ALVO? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore VIR and ALVO comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.